OptiNose is a specialty pharmaceutical company built around a unique nasal delivery platform. The company is driven by an experienced, world-class team with expertise including drug and device development, product manufacturing and commercialization. OptiNose is focused on using its patented technology to identify and develop reduced-risk assets that create significant commercial value by offering meaningful new clinical benefits to patients and healthcare systems.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/04/14 | undisclosed | Series C-1 |
Avista Capital Holdings Entrepreneurs Fund WFD Ventures | undisclosed |
